Julio C Arroyo

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
TO THE EDITOR—The article by Schmader et al [1] summarizing a Zostavax trial in 50to 59-year-old participants raises new concerns and rekindles others [2]. Zostavax vaccine introduces a new virus(More)
  • 1